Mirna Therapeutics, Inc.
Records under this name other than patents Mirna Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Mirna Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,611,478 | Synthetic mimics of miR-124 Lapsed on the fee record Ended Apr 4, 2021 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2021 | USPTO record |
| US 9,540,645 | Compositions and Methods Related to Mirna Modulation of Neovascularization or Angiogenesis Lapsed on the fee record Ended Jan 10, 2021 · High confidence | Lapsed on the fee record | Ended Jan 10, 2021 | High confidence |
| US 9,517,245 | Sorafenib-microRNA combination therapy for liver cancer Lapsed on the fee record Ended Dec 13, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 13, 2020 | USPTO record |
| US 8,258,111 | Compositions and Methods Related to Mirna Modulation of Neovascularization or Angiogenesis Lapsed on the fee record Ended Sep 4, 2020 · High confidence | Lapsed on the fee record | Ended Sep 4, 2020 | High confidence |
| US 9,371,526 | Synthetic mimics of miR-34 Lapsed on the fee record Ended Jun 21, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2020 | USPTO record |
| US 9,365,852 | Compositions and Methods Related to Mirna Modulation of Neovascularization or Angiogenesis Lapsed on the fee record Ended Jun 14, 2020 · High confidence | Lapsed on the fee record | Ended Jun 14, 2020 | High confidence |
| US 9,222,085 | Synthetic mimics of MIR-124 Lapsed on the fee record Ended Dec 29, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 29, 2019 | USPTO record |
| US 8,071,562 | MIR-124 Regulated Genes and Pathways as Targets for Therapeutic Intervention Lapsed on the fee record Ended Dec 6, 2019 · High confidence | Lapsed on the fee record | Ended Dec 6, 2019 | High confidence |
| US 8,900,627 | Novel Compositions for the in Vivo Delivery of Rnai Agents Formerly held Lapsed on the fee record Ended Dec 2, 2018 · High confidence | Lapsed on the fee record | Ended Dec 2, 2018 | High confidence |
| US 8,586,727 | Synthetic mimics of miR-34 Lapsed on the fee record Ended Nov 19, 2017 · USPTO record | Lapsed on the fee record | Ended Nov 19, 2017 | USPTO record |